Navigation Links
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
Date:3/7/2013

nagement Comment"WuXi is succeeding on three fronts: growing, investing to sustain our growth, and returning capital to shareholders," said Dr. Ge Li, Chairman and Chief Executive Officer.  "We achieved strong double-digit revenue growth in the fourth quarter and full year of 2012.  We also achieved double-digit growth in earnings per ADS in 2012.  We continued to invest to build capabilities and capacity in order to sustain revenue and earnings growth for the long term.  While growing and investing, we generated strong free cash flow that allowed us to purchase our shares.

"I am proud of what we accomplished in 2012," Dr. Li continued.  "Revenue growth of 22.8% to about $500 million was driven by continuing growth in demand for WuXi's services in all of our businesses.  In February, we opened a chemistry facility in Wuhan to give our customers a new pricing option.  In October, we began operation of a new cGMP drug-substance biologics manufacturing facility in Wuxi.  We signed many new contracts in biologics, including a joint venture with MedImmune to co-develop their anti-IL6 monoclonal antibody for the China market. We delivered nine small molecule preclinical drug candidates for our clients.  We produced advanced intermediates for five commercial products and grew our late-stage manufacturing pipeline.  The company entered into an agreement to form a joint venture with PRA to offer clinical research services in China.  We purchased 7% of our ADSs outstanding at the beginning of the year.  WuXi achieved year-over-year growth in GAAP diluted EPS of 10.8% and in non-GAAP diluted EPS of 13.3%.  And we continued to invest in building new capabilities and capacities with $67.8 million in new capital assets, to drive future revenue and income growth.

"2013 looks to be another good year.  We expect 13-15% revenue growth, driven by increasing demand across our service offerings.  In
'/>"/>

SOURCE Wuxi PharmaTech Co. Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
2. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
3. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
4. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
5. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
6. WuXi PharmaTech and Open Monoclonal Technology Announce OmniRat(TM) Antibody Collaboration
7. WuXi PharmaTech to Manufacture Ibalizumab for TaiMed Biologics
8. WuXi PharmaTech Receives GLP Certificate from SFDA for Suzhou Toxicology Facility
9. WuXi PharmaTech Announces Second-Quarter 2012 Results
10. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
11. WuXi PharmaTech Announces First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... Nov. 23, 2014  Aurobindo Pharma USA ... Capsules, USP 300 mg 100-count bottles to the consumer ... some empty capsules. Empty capsules could result ... consequences that could range from no effect, short term ... epilepticus (long period seizures) that could be life-threatening. Aurobindo ...
(Date:11/22/2014)... Nov. 22, 2014  New data demonstrates that flibanserin, ... common form of female sexual dysfunction, Hypoactive Sexual Desire ... driving performance in premenopausal women when taken at bedtime. ... of North America,s (SMSNA) 20th ... . SMSNA accepted this study as ...
(Date:11/22/2014)... Pennsylvania , 21 de noviembre de 2014 ... de ensayos clínicos externalizados y tecnologías eClinical, ha ... aproximación de ,seguimiento inteligente, para el seguimiento basado ... seguimiento inteligente amplía el concepto del seguimiento basado ... reducción de las visitas de seguimiento o cambio ...
Breaking Medicine Technology:Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3
... TARRYTOWN, N.Y., April 18, 2012 Bayer HealthCare today ... has cleared its CONTOUR® Next EZ, a new blood ... States.  CONTOUR Next EZ includes an easy-to-use meter and ... new BGM system is being introduced on a market-by-market ...
... launches their Latching Micro-D™ connectors with a new ... quick cable connections to rack and panel equipment.  ... weight, the new latching Micro-D™ connectors, at .050" ... including pull tests that exceeds 100 pound pull ...
Cached Medicine Technology:U.S. FDA Clears Bayer HealthCare's CONTOUR® Next EZ Blood Glucose Monitoring System 2U.S. FDA Clears Bayer HealthCare's CONTOUR® Next EZ Blood Glucose Monitoring System 3Omnetics Launches Panel Mounted Latching Micro-D™ Connectors 2
(Date:11/23/2014)... 2014 (HealthDay News) -- Close friends have more influence ... does, a new study says. "We,ve known ... an influence on individual alcohol use, but there are ... group and the friend group,s influence on those decisions," ... of Public Health, said in a university news release. ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power suppliers are ... announced its new collection of power suppliers. Additionally, it ... power suppliers. All the new models come with big ... until Dec. 20, 2014. , SWAccessControl.com has thousands of ... it for a long time. It is very wise ...
(Date:11/23/2014)... 23, 2014 The FDA is Watching: ... **FDAnews On-Demand Webinar**, Dec. 11, 2014 ? Any Time ... FDA’s focus on promotional activities is no longer limited ... they're looking at websites, Twitter, journal articles, TV appearances, ... Thursday, Dec. 11, for On-Demand access to Timothy Ayers ...
(Date:11/22/2014)... 23, 2014 Every year AlignLife clinics ... AlignLife experience rapid growth in the Greenville, SC area ... opportunity. AlignLife of Simpsonville will be partnering ... their first annual Toy Drive. These six offices came ... support with this year's toy drive. With so many ...
(Date:11/22/2014)... classic black prom dress will never go out of fashion. ... its new items of black prom gowns . Now ... discount, up to 70% off. People throughout the world can ... dresses, made with the best materials, can make wearers feel ... the company provides these beautiful outfits in a huge range ...
Breaking Medicine News(10 mins):Health News:Close Friends May Be Key to Teens' Drinking 2Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:New Black Prom Dresses from BellasDress.com 2
... level of seriously ill patients. This has paved the way ... ,A study, published in the open access journal BMC ... software that assists in the ,monitoring of glucose levels in ... more efficient than the paper-based method which is currently used ...
... SMS message that has been doing the rounds in Saudi ... which was reportedly smuggled into the kingdom will harm the ... of Health. ,The medicine provides relief from fever ... been aware of this issue for about 23 days. The ...
... oil supplements for health is well known. These contain the ... to be heart-protective. ,It has been found that DHA ... in the foetus therefore pregnant women should consume it. ... is warranted here as well. In this case, the concern ...
... under threat from a drinking problem. This result is based ... Addictions Research of B.C. compared drinking patterns of the province ... the Canadian Addiction Survey done in 2004. ,The findings ... for alcohol consumption and 53 per cent were above less ...
... Institute of Cardiovascular Disease (GICD) have identified a growth factor ... //therapies for cardiovascular diseases. ,the study, published in ... of Sciences, focuses on the role of short RNAs in ... These RNAs also called as miRNAs, could play a key ...
... the University of Chicago have announced findings of archeological evidence ... B.C., leading to the destruction of a city. Clemens Reichel, ... excavation was conducted was a war zone. Artifacts from daily ... Syria at the Iraqi border. ,The findings ...
Cached Medicine News:Health News:Excavations Reveal Clues Of Early Warfare 2
Tying forceps with flat serrated handle 88 mm, made of titanium, angled 30 with 4.5 mm tying platform....
Thornton titanium curved suture tying forceps, 4"....
Castroviejo McPherson angled tying forceps with 10 mm tips and 5mm titanium coated platforms. Length 110 mm....
Round handle curved tying forceps with 5 mm titanium coated platforms. Length 110 mm....
Medicine Products: